Magretta Adiamah Beth Poole Dr Janet Lindsey Dr Rebecca Hill Dr Helen Blair et al. | MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma | 2025 |
|
Jemma Castle Dr Edward Fielder Mankaran Singh Professor Roderick Skinner Professor Thomas von Zglinicki et al. | In vivo modeling recapitulates radiotherapy delivery and late-effect profile for childhood medulloblastoma | 2024 |
|
Dr Hayden Bell Dr Helen Blair Mankaran Singh Professor Anthony Moorman Professor Olaf Heidenreich et al. | Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia | 2023 |
|
Dr Deepali Pal Dr Helen Blair Sean Hockney Dr Melanie Beckett Mankaran Singh et al. | hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia | 2022 |
|